Hypertrophic and Keloid Scar Treatment Market Size is Expected to Reach at USD 15.7 Billion by 2030, Registering a CAGR of 10%, Owing to Rising Incidences of Injuries and Surgeries
The Global Hypertrophic and Keloid Scar Treatment Market Size is predicted to reach USD 15.7 Billion by 2030 from USD 6.8 Billion in 2021, at a CAGR of 10% between 2022 and 2030, as per the Acumen Research and Consulting
The hypertrophic and keloid scar treatment market is continually expanding, with new technologies and therapies being developed and approved for usage. This involves the use of silicone sheets and gels, laser therapy, and injectable therapies such as corticosteroids and 5-FU. Furthermore, there is growing interest in employing natural and alternative therapies to help minimize the appearance of scars, such as essential oils and herbal supplements. Overall, the market is expected to grow in the coming years as more effective treatments become available and awareness of scar treatment options increases.
The Hypertrophic and keloid scar treatment market refers to the various products, services, and treatments that are used to reduce the appearance of hypertrophic and keloid scars. These types of scars are formed when the body overproduces collagen, leading to raised, thick, and sometimes itchy or painful scars. Treatments for hypertrophic and keloid scars include silicone sheets and gels, laser therapy, injectable treatments, and natural and alternative therapies. The market for these treatments includes medical professionals and clinics, as well as manufacturers and distributors of the products and devices used in treatment.
Hypertrophic and Keloid Scar Treatment Market Statistics
- Global hypertrophic and keloid scar treatment market value was worth USD 6.8 Billion in 2021, with a 10% CAGR from 2022 to 2030
- According to studies, keloids affect 10% of the world's population
- North America hypertrophic and keloid scar treatment market share occupied around 35.1% in 2021
- By scar type, the keloid capture over 64.8% of total market share in 2021
- Growing acceptance of minimally invasive treatments, propels the hypertrophic and keloid scar treatment market size
Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/964
Hypertrophic and Keloid Scar Treatment Market Trends
The market for hypertrophic and keloid scar treatment is evolving with increasing adoption of minimally invasive treatments, rising demand for natural and alternative therapies, growing awareness about scar treatment options, advancements in technology, and an increasing number of injuries and surgeries. Additionally, telemedicine is becoming more popular, which is expected to boost market growth in the near future. These trends are driving the growth of the hypertrophic and keloid scar treatment market.
Rising Incidences of Injuries and Surgeries Drive the Hypertrophic and Keloid Scar Treatment Market Growth
Rising incidences of injuries and surgeries are one of the major drivers of the hypertrophic and keloid scar treatment market revenue. As the number of injuries and surgeries increases, so does the demand for scar treatment. According to the World Health Organization (WHO), estimated 234 million major surgeries are performed globally each year, and this number is expected to increase in the future due to the aging population and the increasing prevalence of chronic diseases. Additionally, the number of accidents and injuries also continues to rise, further driving the demand for scar treatment. With the increasing number of injuries and surgeries, the market for scar treatment is expected to grow as more people seek treatment for their scars.
Hypertrophic and Keloid Scar Treatment Market Segmentation
Acumen Research and Consulting has segmented the global hypertrophic and keloid scar treatment market by scar type, end-user, and product.
- Based on the scar type, the industry is categorized into keloid, and hypertrophic. According to the hypertrophic and keloid scar treatment market forecast, the keloid segment is estimated to grow significantly over the next several years.
- Based on the end-user, the market is divided into hospitals, retail pharmacies/e-commerce, and clinics.
- Based on the product, the market is divided into topical products (gels, creams, silicone sheets, and others), injectable, laser product (CO2, pulse-dyed, and others), and others.
Hypertrophic and Keloid Scar Treatment Market Regional Overview
Geographically, the worldwide hypertrophic and keloid scar treatment market is segmented into Latin America, Europe, North America, Asia Pacific, and the MEA. As per hypertrophic and keloid scar treatment industry analysis, the North American market is expected to grow at a significant rate throughout the forecast period. This growth is attributed to the region's growing frequency of burns, injuries, and surgeries. Furthermore, rising scar management awareness and the availability of sophisticated treatment options are propelling market expansion. The region's demand for minimally invasive and non-invasive therapies is also predicted to rise. The United States commands the highest market share, followed by Canada. Major players operating in the North American market include Allergan, Merz, Suneva Medical, Sinclair Pharma, and CCA Industries.
Hypertrophic and Keloid Scar Treatment Market Players
Some of the leading hypertrophic and keloid scar treatment market companies include Perrigo Company PLC, Lumenis Ltd., Sonoma Pharmaceuticals, Inc., Merz Pharmaceuticals, LLC, Suneva Medical, Inc., Smith & Nephew PLC, Mölnlycke Health Care AB, Cynosure, Inc., Enaltus, LLC, Alliance Pharma, PLC, and Newmedical Technology, Inc.
Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/964
Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/964
Mr. Frank Wilson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
